Zobrazeno 1 - 10 of 2 554 pro vyhledávání: '"de Launoit, Y."'
2
Akademický článek
[Sorting of senescent cells by flow cytometry: Specificities and pitfalls to avoid].
Autor: Rodzinski É; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Martin N; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Rouget R; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Pioger A; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Dehennaut V; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Molendi-Coste O; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US41 - UAR 2014 - PLBS, F-59000 Lille, France., Dombrowicz D; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011 - EGID, F-59000 Lille, France., Goy E; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., de Launoit Y; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France., Abbadie C; Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER (Cancer Heterogeneity Plasticity and Resistance to Therapies), F-59000 Lille, France.
Publikováno v: Medecine sciences : M/S [Med Sci (Paris)] 2024 Mar; Vol. 40 (3), pp. 275-282. Date of Electronic Publication: 2024 Mar 22.
Zobrazit plný text záznamu
3
Akademický článek
Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
Autor: Turpin A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France., Delliaux C; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Parent P; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Lille University Hospital, F-59000, Lille, France., Chevalier H; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France., Escudero-Iriarte C; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Bonardi F; University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000, Lille, France., Vanpouille N; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Flourens A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Querol J; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Carnot A; Department of Medical Oncology, Centre Oscar Lambret, 3, rue Frederic Combemale, 59000, Lille, France., Leroy X; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France., Herranz N; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Lanel T; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Institut de Pathologie, CHU Lille, Avenue Oscar Lambret, F-59000, Lille, France., Villers A; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France., Olivier J; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.; Department of Urology, Hospital Claude Huriez, CHU Lille, Lille, France., Touzet H; University Lille, CNRS, Centrale Lille, UMR 9189 CRIStAL, F-59000, Lille, France., de Launoit Y; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France., Tian TV; Vall d'Hebron Institute of Oncology (VHIO), 08035, Barcelona, Spain., Duterque-Coquillaud M; University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France. martine.duterque@cnrs.fr.
Publikováno v: British journal of cancer [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 1903-1914. Date of Electronic Publication: 2023 Oct 24.
Zobrazit plný text záznamu
5
Akademický článek
Flow Cytometry-based Method for Efficient Sorting of Senescent Cells.
Autor: Goy E; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Martin N; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Drullion C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Saas L; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Molendi-Coste O; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France., Pineau L; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France., Dombrowicz D; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France., Deruy E; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Bauderlique-Le-Roy H; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US41 - UAR 2014 - PLBS, F-59000 Lille, France., Samyn O; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., De Launoit Y; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Abbadie C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France.
Publikováno v: Bio-protocol [Bio Protoc] 2023 Apr 05; Vol. 13 (7), pp. e4612. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).
Zobrazit plný text záznamu
6
Akademický článek
Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Autor: Xu, Qianqian1 (AUTHOR), Li, Jiayi1,2 (AUTHOR), Yang, Yue1 (AUTHOR), Zhuo, Li1 (AUTHOR), Gao, Hongmei1 (AUTHOR), Jiang, Shimin1 (AUTHOR), Li, Wenge1,2 (AUTHOR) wenge_lee2002@126.com
Publikováno v: Renal Failure. Dec2024, Vol. 46 Issue 2, p1-10. 10p.
Zobrazit plný text záznamu
7
Akademický článek
Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin E 2 Production and Exerts a Protective Effect on Colitis Induced by Trinitrobenzene Sulfonic Acid in Mice.
Autor: Kojima, Fumiaki1,2,3 (AUTHOR) kawakami@kitasato-u.ac.jp, Hioki, Yuka1,2 (AUTHOR) t.ichika@kitasato-u.ac.jp, Sekiya, Hiroki1,2 (AUTHOR), Kashiwagi, Hitoshi4 (AUTHOR) h-kashi@pharm.hokudai.ac.jp, Iizuka, Yoshiko3,5 (AUTHOR) keieto@kitasato-u.ac.jp, Eto, Kei3,6 (AUTHOR) smaehana@kitasato-u.ac.jp, Maehana, Shotaro3,7 (AUTHOR) kuboma@kitasato-u.ac.jp, Kawakami, Fumitaka2,3 (AUTHOR) isibasih@kitasato-u.ac.jp, Kubo, Makoto3,7 (AUTHOR), Ishibashi, Hitoshi3,6 (AUTHOR), Ichikawa, Takafumi2,3 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12326. 14p.
Zobrazit plný text záznamu
8
Akademický článek
Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas.
Autor: Sánchez-Castillo, Anaís1 (AUTHOR), Savelkouls, Kim G.1 (AUTHOR), Baldini, Alessandra1 (AUTHOR), Hounjet, Judith1 (AUTHOR), Sonveaux, Pierre2,3 (AUTHOR), Verstraete, Paulien4 (AUTHOR), De Keersmaecker, Kim4 (AUTHOR), Dewaele, Barbara5 (AUTHOR), Björkblom, Benny6 (AUTHOR), Melin, Beatrice7 (AUTHOR), Wu, Wendy Y.7 (AUTHOR), Sjöberg, Rickard L.8 (AUTHOR), Rouschop, Kasper M. A.1 (AUTHOR), Broen, Martijn P. G.9 (AUTHOR), Vooijs, Marc1 (AUTHOR), Kampen, Kim R.1,4 (AUTHOR) k.kampen@maastrichtuniversity.nl
Publikováno v: Oncogenesis. 11/13/2024, Vol. 13 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
9
Akademický článek
Apoptotic Caspases Suppress Expression of Endogenous Retroviruses in HPV31+ Cells That Are Associated with Activation of an Innate Immune Response.
Autor: Studstill, Caleb1,2 (AUTHOR), Huang, Ning1,2 (AUTHOR), Sundstrom, Shelby2 (AUTHOR), Moscoso, Samantha2 (AUTHOR), Zhang, Huirong2 (AUTHOR), Damania, Blossom1,2 (AUTHOR), Moody, Cary1,2 (AUTHOR) camoody@med.unc.edu
Publikováno v: Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1695. 14p.
Zobrazit plný text záznamu
10
Viral oncoproteins target the DNA methyltransferases
Autor: Burgers, T, Blanchon, Loïc, Pradhan, S, de Launoit, Y, Kouzarides, T, Fuks, F, Burgers, W, Launoit, y De
Publikováno v: Oncogene
Oncogene, 2007, 26 (11), pp.1650-1655. ⟨10.1038/sj.onc.1209950⟩
Oncogene, Nature Publishing Group, 2007, 26 (11), pp.1650-1655. ⟨10.1038/sj.onc.1209950⟩
International audience; Small DNA tumour viruses have evolved a number of mechanisms to drive nondividing cells into S phase. Virally encoded oncoproteins such as adenovirus E1A and human papillomavirus (HPV) E7 can bind an array of cellular proteins
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dad3ba725d3b29f45198440919e2a70
https://doi.org/10.1038/sj.onc.1209950
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje